Voxmind | $735,203 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
Certified by Founder
Lodge
NewLeaf Symbiotics, Inc.
start up
United States
- St. Louis, Missouri
- 21/12/2023
- Series D
- $45,000,000
NewLeaf Symbiotics is the industry’s undisputed Ag Biotech leader and pioneer of PPFM technology. The proud Champions of Pink Performance, NewLeaf works to harness pink-pigmented facultative methylotrophs – PPFMs – into actionable solutions to challenges around yield, crop protection, nutrient use efficiency and methane mitigation, with the intent of helping farmers do more with less as they work to feed a growing population.
- Industry Biotechnology Research
- Website https://www.newleafsym.com/
- LinkedIn https://www.linkedin.com/company/newleaf-symbiotics-inc-/
Inherent | $50,000,000 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Handshake(UK) | $3,200,000 | (Jun 2, 2026)
Sekai(US) | $26,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Perceptic | $12,000,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
MokN | $15,000,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)